可变形术前模型增强现实在腹腔镜肝切除中的病例系列研究
该病例系列研究评估了Hepataug软件在腹腔镜肝切除中半自动叠加可变形术前模型进行增强现实(AR)引导的可行性。2017年7月至2019年3月连续纳入17例患者,所有手术AR均可行且与腹腔镜超声(LUS)相关性良好,2例LUS未显示肿瘤位置时Hepataug提供了预测并经术前影像确认。结论认为Hepataug对手术流程干扰小、结果可重复,但需前瞻性对比研究验证疗效。
要点
- Hepataug可半自动将可变形术前模型叠加于腹腔镜图像,实现AR引导。
- 17例腹腔镜肝切除中AR均可行,与LUS相关性良好。
- 2例LUS未定位肿瘤时,Hepataug预测位置经术前CT或MRI确认。
核心结论
- Hepataug对手术流程干扰小,可在真实肝切除手术中可行使用。
- 其半自动可变形对齐机制与LUS及术前CT或MRI视觉检查在 subsurface 肿瘤定位中一致性良好,结果可重复、易于使用,可部署于现有手术室。
- 仍需前瞻性对比研究评估其疗效。
研究设计与样本
- 单中心病例系列研究,2017年7月至2019年3月连续纳入17例接受腹腔镜肝切除的患者。
- 术中运行Hepataug,并与常规腹腔镜超声(LUS)及术前CT或MRI视觉检查对照。
- 主要目标为评估Hepataug对手术流程干扰最小的可行性;次要目标为通过与LUS主观比较评估潜在获益。
主要发现
- 所有17例手术中AR均可行,且与LUS相关性良好。
- 2例患者LUS未揭示肿瘤位置,Hepataug给出肿瘤位置预测,经仔细检查术前CT或MRI确认并细化。
- Hepataug对手术流程干扰小,结果可重复。
临床怎么用
- 在腹腔镜肝切除中,Hepataug可作为辅助定位手段,与LUS及术前影像联合使用。
- 当LUS难以定位肿瘤时,可参考Hepataug的预测位置,但需经术前CT或MRI确认。
- 该技术易于使用,可部署于现有手术室。
局限性
- 为病例系列研究,样本量17例,未设对照组。
- 疗效需前瞻性对比研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous work in augmented reality (AR) guidance in monocular laparoscopic hepatectomy requires the surgeon to manually overlay a rigid preoperative model onto a laparoscopy image. This may be fairly inaccurate because of significant liver deformation. We have proposed a technique which overlays a deformable preoperative model semi-automatically onto a laparoscopic image using a new software called Hepataug. The aim of this study is to show the feasibility of Hepataug to perform AR with a deformable model in laparoscopic hepatectomy. METHODS: We ran Hepataug during the procedures, as well as the usual means of laparoscopic ultrasonography (LUS) and visual inspection of the preoperative CT or MRI. The primary objective was to assess the feasibility of Hepataug, in terms of minimal disruption of the surgical workflow. The secondary objective was to assess the potential benefit of Hepataug, by subjective comparison with LUS. RESULTS: From July 2017 to March 2019, 17 consecutive patients were included in this study. AR was feasible in all procedures, with good correlation with LUS. However, for 2 patients, LUS did not reveal the location of the tumors. Hepataug gave a prediction of the tumor locations, which was confirmed and refined by careful inspection of the preoperative CT or MRI. CONCLUSION: Hepataug showed a minimal disruption of the surgical workflow and can thus be feasibly used in real hepatectomy procedures. Thanks to its new mechanism of semi-automatic deformable alignment, Hepataug also showed a good agreement with LUS and visual CT or MRI inspection in subsurface tumor localization. Importantly, Hepataug yields reproducible results. It is easy to use and could be deployed in any existing operating room. Nevertheless, comparative prospective studies are needed to study its efficacy.
引用
- Bertrand LR, Abdallah M, Espinel Y, et al. A case series study of augmented reality in laparoscopic liver resection with a deformable preoperative model. Surg Endosc. 2020. PMID: 32691206. doi:10.1007/s00464-020-07815-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。